Author:
Li Kewei,Xu Yongzhi,Tan Mingyue,Xia Shujie,Xu Zhonghua,Xu Dongliang
Funder
Shanghai Science and Technology Committee
Shanghai Hospital Development Center
Foundation of Shanghai Municipal Commission of Health and Family Planning
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Ferlay I Soerjomataram I Ervik M et al Globocan 2012, Estimated cancer incidence, mortality and prevalence worldwide in 2012. GLOBOCAN 2012 (IARC) Section of Cancer Surveillance (1/12/2017)
2. Divrik RT, Sahin AF, Yildirim U, Altok M, Zorlu F (2010) Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial. Eur Urol 58:185–190
3. Babjuk M, Burger M, Zigeuner R et al (2013) EAU guidelines on non–muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol 64:639–653
4. Cao M, Yang G, Pan J et al (2015) Repeated transurethral resection for non-muscle invasive bladder cancer. Eur Urol Int J Clin Exp Med 8(1):1416–1419
5. Brausi M, Witjes JA, Lamm D et al (2011) A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group. J Urol 186:2158–2167
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献